| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $44.5M | +17.6% |
| Cost of Revenue | $6.7M | +1.2% |
| R&D Expense | $5.6M | +15.6% |
| SG&A Expense | $11.9M | +7.4% |
| Operating Income | -$2.8M | +56.6% |
| Interest Expense | $496K | -18.1% |
| Pre-tax Income | -$2.8M | +56.5% |
| Income Tax | $40K | +277.6% |
| Net Income | -$2.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.4M | -36.3% |
| Accounts Receivable | $16.9M | +44.8% |
| Inventory | $6.2M | +55.6% |
| Current Assets | $37.1M | +1.7% |
| Total Assets | $76.8M | +1.6% |
| Current Liabilities | $36.7M | +16.2% |
| Total Liabilities | $52.3M | -1.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.9M | +905.7% |
| Capital Expenditures | $98K | +47.3% |
| Investing Cash Flow | -$4.7M | -8236.8% |
| Financing Cash Flow | -$6.7M | -3525.8% |
| Free Cash Flow | $4.8M | +812.4% |
| +56.2% |
| EPS (Basic) | -$0.19 | +58.7% |
| EPS (Diluted) | -$0.19 | +58.7% |
| Stockholders' Equity |
| $24.9M |
| +8.9% |